Instruction for use: Apo-Oxtriphylline

Dosage form: coated tablets

Active substance: Cholini theophyllinas

ATX

R03DA02 Choline theophylline

Pharmacological group

Adenosinergic agents

The nosological classification (ICD-10)

J40 Bronchitis not specified as acute or chronic: Asthmatic bronchitis; Allergic bronchitis; Bronchitis allergic; Asthmatic bronchitis; Rhinotraheobronchitis; Asthmatic bronchitis; Bacterial bronchitis; Bronchitis; Bronchitis of the smoker; Bronchitis of smokers; Inflammation of the lower respiratory tract; Disease of the bronchi; Qatar smoker; Cough smokers; Cough with inflammatory diseases of the lungs and bronchi; Disturbance of bronchial secretion; Impaired bronchial function; Acute tracheobronchitis; Subacute bronchitis; Tracheobronchitis; Chronic lung diseases

J43 Emphysema: Interstitial emphysema; Emphysema of the lungs; Chronic lung diseases; Chronic Obstructive Pulmonary Diseases; Obstructive emphysema of the lungs; Chronic emphysema of the lungs; Chronic obstructive pulmonary emphysema

J45 Asthma: Asthma of physical effort; Asthmatic conditions; Bronchial asthma; Bronchial asthma of light course; Bronchial asthma with difficulty in sputum discharge; Bronchial asthma of severe course; Bronchial asthma physical effort; Hypersecretory asthma; The hormone-dependent form of bronchial asthma; Curbing asthma attacks with bronchial asthma; Non-allergic bronchial asthma; Night Asthma; Exacerbation of bronchial asthma; Attack of bronchial asthma; Endogenous forms of asthma; Night attacks of asthma; Cough with bronchial asthma

Composition and release form

1 tablet contains choline theophyllinate (theophylline 64%) 100, 200 or 300 mg, in plastic bottles of 100 or 500 pcs.

Pharmacology

Mode of action - bronchodilator, psychostimulating, stimulating neuromuscular transmission.

Pharmacokinetics

After oral administration, it is quickly and fully absorbed, evenly distributed in the media and tissues of the body. The connection with plasma proteins is 55-65% (at a therapeutic concentration in plasma from 8 to 20 mkg / ml). T1 / 2 4.5 hours (1.5-9.5 hours). The equilibrium plasma concentration is created after 1-2 days. Metabolised in the liver. About 10% is excreted by the kidneys.

Indications of Apo-Oxtriphylline

Bronchoobstructive syndrome, bronchial asthma, chronic obstructive bronchitis, obstructive pulmonary emphysema.

Contraindications

Hypersensitivity, gastric ulcer and duodenal ulcer in the acute phase, acute myocardial infarction, acute heart failure, age (up to 10 years).

Side effects

Dyspeptic disorders, peptic ulcer and duodenal ulcers, bleeding from the digestive tract, headache, nervousness, insomnia, convulsions, tachycardia, hypotension, collapse, leukopenia, anemia, allergic reactions (urticaria, pruritus, dermatitis).

Interaction

Potentiates the action of diuretics and cardiac glycosides. Reduces the uricosuric effect of probenecid and pyrazolones, the action of lithium carbonate. Concentration in the blood raises erythromycin. The action is potentiated by influenza vaccine and cimetidine. Excretion is increased by substances acidifying the urine, decreasing - alkalinizing. Bronchodilation is enhanced by sympathomimetics. There is antagonism with coumarin anticoagulants and propranolol. Incompatible with morphine and curare-like drugs (bronchospasm may develop). Simultaneous administration of other xanthines can cause excessive CNS excitation.

Dosage and Administration

Inside for 200-400 mg 4 times a day (maintenance dose 800-1200 mg per day). For children aged 10-14 years, the initial daily dose - 22 mg / kg in 4 divided doses, supporting - 15-22 mg / kg in 4 divided doses.

Overdose

Symptoms: nausea, vomiting, epigastric pain, bloody vomiting, diarrhea, hyperreflexia, fasciculation, clonic and tonic convulsions (especially in children), hypotension and circulatory disorders, albuminuria and microhematuria, fainting, collapse, fever and dehydration.

Precautionary measures

Children receiving Apo-Oxtriphylline should not prescribe other xanthine derivatives, including rectally. During the treatment it is recommended to control the concentration of theophylline in the blood.

Storage conditions of Apo-Oxtriphylline

In a well ukuporennoy container.

Keep out of the reach of children.

Shelf life of the drug Apo-Oxtriphylline

4 years.

Do not use after the expiry date printed on the package.